key: cord-0826092-sp7a4l0q
authors: Wang, Haizhou; Wang, Fan; Wang, Hongling; Zhao, Qiu
title: Potential infectious risk from the pets carrying SARS-CoV-2
date: 2020-05-05
journal: Travel Med Infect Dis
DOI: 10.1016/j.tmaid.2020.101737
sha: c1335ae9c8ec9452811cb5bf43d2baca6263ed06
doc_id: 826092
cord_uid: sp7a4l0q

nan

that cats could be infected with SARS-CoV-2 [1]. In addition, Hong Kong Department of Agriculture, Fisheries and Conservation also reported a SARS-CoV-2carrying pet dog from a COVID-19 patient family. Samples from the dog's mouth, nasal cavity, and anus were tested for the virus nucleic acid, and showed weakly positive in oral and nasal samples [2] .

These aroused our great concern on the pets, mainly mammals, such as cats and dogs, which may be potential carriers of SARS-CoV-2. In the previous SARS-CoV . The findings greatly promoted our understanding of the infectious mechanism of SARS-CoV-2 on human cells. Paralleling this, ACE2 was also expressed in the kidney and myocardial tissues of cats and dogs [5] . Sequencing of domestic cat lung tissues further revealed 85% similarity in the amino acid between cat and ACE2. More importantly, three ACE2 domains associated with SARS-CoV in the cat have the highest homology with human ACE2, suggesting that cats may be involved in SARS-CoV-2 interspecies infection [6] .

To prevent pets from transmitting SARS-CoV-2 to humans, surveillance and isolation should be emphasized. First, during the COVID-19 outbreak, the pet owners should not take their pets out to those high-risk areas, even if they do, the pets should be tested. Second, for diagnosed COVID-19 patients, their pets need a surveillance and isolation to rule out the possibility of infection. Finally, for the recovered owners, their pets should be also tested and kept in quarantine. These recovered patients might be re-infected when they lived with the SARS-CoV-2carrying pets again after discharge. Recently, some previously recovered COVID-19 patients had a positive virus detection. It was not clear whether it derived from the residual viruses in the body or the viruses in the environment from infected pets.

We declare no competing interests.

1

Zhang Q, Zhang H, Huang K, Yang Y, Hui X, Gao J, He X, Li C, Gong W, Zhang Y, Peng C, Gao X, Chen H, Zou Z, Shi Z and Jin M. SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation. bioRxiv 2020;

published online April 3. https://doi.org/10.1101/2020.04.01.021196 (preprint).

of the SARS-CoV-2 by full-length human ACE2

Plasma and Tissue Angiotensin-Converting Enzyme 2 Activity and Plasma Equilibrium Concentrations of Angiotensin Peptides in Dogs with Heart Disease

Domestic Cat ACE2 Gene Cloning, Sequencing and Bioinformatic Analysis

Declarations Travel Medicine and Infectious Disease requires that all authors sign a declaration of conflicting interests. If you have nothing to declare in any of these categories then this should be stated.

A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

We declared no competing interests

All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated.